| Literature DB >> 24371770 |
Keiko Niimi1, Hitoshi Kiyoi1, Yuichi Ishikawa1, Fumihiko Hayakawa1, Shingo Kurahashi1, Rika Kihara1, Akihiro Tomita1, Tomoki Naoe1.
Abstract
We identified two novel GATA2 mutations in acute myeloid leukemia (AML). One mutation (p.R308P-GATA2) was a R308P substitution within the zinc finger (ZF)-1 domain, and the other (p.A350_N351ins8-GATA2) was an eight-amino-acid insertion between A350 and N351 residues within the ZF-2 domain. p.R308P-GATA2 did not affect DNA-binding and transcriptional activities, while p.A350_N351ins8-GATA2 reduced them, and impaired G-CSF-induced granulocytic differentiation of 32D cells. Although p.A350_N351ins8-GATA2 did not show a dominant-negative effect over wild-type (Wt)-GATA2 by the reporter assay, it might be involved in the pathophysiology of AML by impairing myeloid differentiation because of little Wt-GATA2 expression in primary AML cells harboring the p.A350_N351ins8 mutation.Entities:
Keywords: AML; Differentiation; GATA2; Mutation
Year: 2013 PMID: 24371770 PMCID: PMC3850381 DOI: 10.1016/j.lrr.2013.02.002
Source DB: PubMed Journal: Leuk Res Rep ISSN: 2213-0489